Clinical Trial Update: Exclusion of the Left Atrial Appendage (LAA) With the LAAx, Inc. TigerPaw System [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the TigerPaw System for left atrial appendage exclusion in stroke prevention.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• TigerPaw System

Snippet

Sponsor: LAAx, Inc. | Conditions: Stroke | Phase 2 | Status: UNKNOWN